Clinical Reporting Anchor and Disclosure (1452)

Trials

Studies that name Clinical Reporting Anchor and Disclosure (1452) as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:20 UTC. Open this list on ClinicalTrials.gov

• Ph3
  NCT04596631 · A Research Study to Compare a New Medicine Oral Semaglutide to a Dummy Medicine in Children and Teenagers With Type 2 Diabetes

  Novo Nordisk A/S · completed · Diabetes Mellitus, Type 2 · study director
• N/A
  NCT04584892 · Turoctocog Alfa in Haemophilic Italian Patients: Protection and Engagement in Recreational Activities

  Novo Nordisk A/S · completed · Haemophilia A
• Ph1
  NCT04524832 · Research Study Comparing New Tablets of Semaglutide in New Doses, in Healthy People

  Novo Nordisk A/S · completed · Diabetes Mellitus, Type 2
• Ph1
  NCT04513704 · A Clinical Trial Comparing Semaglutide in Healthy People Who Eat and Take the Medicine at Different Times

  Novo Nordisk A/S · completed · Healthy Volunteers Type 2 Diabetes
• N/A
  NCT04469855 · Post-Marketing Surveillance (Special Use-results Surveillance) on Long-term Use With Ozempic®

  Novo Nordisk A/S · completed · Diabetes Mellitus, Type 2 · study director
• N/A
  NCT04444856 · Clinical Outcomes of NovoSeven® Treatment in Severe Postpartum Haemorrhage - a Study at the University Hospital of Bern

  Novo Nordisk A/S · completed · Severe Postpartum Haemorrhage · study director
• N/A
  NCT04315688 · A Research Study, Looking at How Tresiba® Works in People With Type 2 Diabetes in Local Clinical Practice in Russia

  Novo Nordisk A/S · completed · Diabetes Mellitus, Type 2 · study director
• Ph1
  NCT04238962 · A Research Study to Compare Two Different Forms of Once-weekly Semaglutide in Two Different Injection Pens

  Novo Nordisk A/S · completed · Overweight, Obesity · study director
• N/A
  NCT04227431 · A Research Study, Looking at How Tresiba® Works in People With Type 2 Diabetes in Local Clinical Practice in China

  Novo Nordisk A/S · completed · Diabetes Mellitus, Type 2 · study director
• Ph1
  NCT04209049 · A Research Study Looking Into Blood Levels of NNC0174-0833 in People With Normal and Impaired Kidney Function

  Novo Nordisk A/S · completed · Overweight, Obesity · study director
• Ph2
  NCT04204408 · A Research Study Investigating Mim8 in People With Haemophilia A

  Novo Nordisk A/S · completed · Healthy Volunteers, Haemophilia A With or Without Inhibitors · study director
• Ph4
  NCT04189848 · Comparison of Injection Site Pain Experience for Semaglutide and Dulaglutide sc

  Novo Nordisk A/S · completed · Healthy Volunteers, Diabetes Mellitus, Type 2, Overweight · study director
• Ph1
  NCT04187300 · A Research Study Looking at the Comparability (Bioequivalence) of Two Forms of Semaglutide in Two Different Pen-injectors in People With Overweight or Obesity

  Novo Nordisk A/S · completed · Overweight, Obesity · study director
• Ph1
  NCT04152915 · A Research Study Looking at Similarity Between Once-weekly Semaglutide Versions for Different Injection Pens

  Novo Nordisk A/S · completed · Healthy Volunteers, Diabetes Mellitus, Type 2 · study director
• Ph2
  NCT04143945 · A Study Comparing the Injection Site Pain Experience After the Injection of Semaglutide B and Semaglutide D With 2 Different Injection Pens, a Compound for the Treatment of Type 2 Diabetes and Obesity

  Novo Nordisk A/S · completed · Healthy Volunteers Diabetes Mellitus, Type 2, Healthy Volunteers Overweight, Healthy Volunteers Obesity · study director
• Ph1
  NCT04136067 · A Study to Look at How Safe NNC0268-0965 is in People With Type 2 Diabetes

  Novo Nordisk A/S · completed · Diabetes Mellitus, Type 2 · study director
• Ph3
  NCT04109547 · A Research Study Comparing a New Medicine Oral Semaglutide to Placebo in People With Type 2 Diabetes

  Novo Nordisk A/S · completed · Diabetes Mellitus, Type 2 · study director
• Ph1
  NCT04109508 · A Research Study Comparing Active Drug in the Blood in Healthy Participants Following Dosing of the Current and a New Formulation (C) Semaglutide Tablets

  Novo Nordisk A/S · completed · Healthy Volunteers, Type 2 Diabetes · study director
• Ph3
  NCT04102189 · A Research Study on How Well Semaglutide Works in Adolescents With Overweight or Obesity

  Novo Nordisk A/S · completed · Overweight, Obesity · study director
• Ph1
  NCT04097600 · A Research Study Comparing Active Drug in the Blood in Healthy Participants Following Dosing of the Current and a New Formulation (D) Semaglutide Tablets

  Novo Nordisk A/S · completed · Healthy Volunteers, Type 2 Diabetes · study director
• N/A
  NCT04094415 · A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Italy, as Part of Local Clinical Practice

  Novo Nordisk A/S · completed · Diabetes Mellitus, Type 2 · study director
• Ph3
  NCT04083781 · Research Study to Look at How Well the Drug Concizumab Works in Your Body if You Have Haemophilia With Inhibitors

  Novo Nordisk A/S · active not recruiting · Haemophilia A With Inhibitors, Haemophilia B With Inhibitors · study director
• N/A
  NCT04083820 · A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in France, as Part of Local Clinical Practice (SURE FRANCE)

  Novo Nordisk A/S · completed · Diabetes Mellitus, Type 2 · study director
• Ph3
  NCT04082429 · Research Study to Look at How Well the Drug Concizumab Works in Your Body if You Have Haemophilia Without Inhibitors

  Novo Nordisk A/S · active not recruiting · Haemophilia A Without Inhibitors, Haemophilia B Without Inhibitors · study director
• Ph1
  NCT04074174 · Research Study to Investigate the Effect of NNC0174-0833 on a Birth Control Pill in Women Who Are Not Able to Become Pregnant

  Novo Nordisk A/S · completed · Overweight, Obesity · study director
• Ph3
  NCT04074161 · Research Study to Investigate How Well Semaglutide Works Compared to Liraglutide in People Living With Overweight or Obesity

  Novo Nordisk A/S · completed · Overweight, Obesity · study director
• N/A
  NCT04067999 · A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Spain, as Part of Local Clinical Practice

  Novo Nordisk A/S · completed · Diabetes Mellitus, Type 2 · study director
• Ph1
  NCT04059367 · Research Study to Investigate How a Study Medicine (NNC9204- 1177) Affects Blood Levels of Other Medicines in Healthy People

  Novo Nordisk A/S · completed · Healthy Volunteers, Overweight, Obesity · study director
• Ph1
  NCT04058834 · A Research Study Investigating How NNC0385-0434 is Tolerated in People With or Without High Cholesterol Levels

  Novo Nordisk A/S · completed · Healthy Volunteers, Hypercholesterolaemia · study director
• N/A
  NCT04042441 · A Research Study, Looking at How Ryzodeg® (Insulin Degludec/Insulin Aspart) Works in People With Type 2 Diabetes in Local Clinical Practice

  Novo Nordisk A/S · completed · Diabetes Mellitus, Type 2 · study director
• Ph1
  NCT04032197 · A Research Study of How Semaglutide Works in People With Disease Affecting the Heart and/or Blood Vessels and Type 2 Diabetes

  Novo Nordisk A/S · completed · Diabetes Mellitus, Type 2 · study director
• Ph3
  NCT04017832 · A Research Study Comparing a New Medicine Oral Semaglutide to Sitagliptin in People With Type 2 Diabetes

  Novo Nordisk A/S · completed · Diabetes Mellitus, Type 2 · study director
• Ph1
  NCT04016974 · A Research Study of How Oral Semaglutide Tablets Work in Healthy People Who Are Chinese

  Novo Nordisk A/S · completed · Healthy Volunteers, Diabetes Mellitus, Type 2 · study director
• Ph1
  NCT04012255 · A Research Study to Compare Two Forms of Semaglutide in Two Different Pen-injectors in People With Overweight or Obesity

  Novo Nordisk A/S · terminated · Overweight, Obesity · study director
• Ph1
  NCT04010786 · A Research Study Investigating NNC0247-0829 for Weight Management in People With Overweight or Obesity

  Novo Nordisk A/S · completed · Overweight, Obesity · study director
• Ph2
  NCT04007107 · A Study Comparing the Injection Site Pain Experience After the Injection of 2 Different Solutions of Semaglutide With 2 Different Injection Pens, a Compound for the Treatment of Type 2 Diabetes and Obesity

  Novo Nordisk A/S · completed · Healthy Volunteers Diabetes Mellitus, Type 2, Healthy Volunteers Overweight, Healthy Volunteers Obesity · study director
• Ph3
  NCT03989232 · A Research Study to Compare Two Doses of Semaglutide Taken Once Weekly in People With Type 2 Diabetes

  Novo Nordisk A/S · completed · Diabetes Mellitus, Type 2 · study director
• Ph2
  NCT03987451 · A Research Study on How Semaglutide Works in People With Fatty Liver Disease and Liver Damage

  Novo Nordisk A/S · completed · Non-alcoholic Steatohepatitis · study director
• N/A
  NCT03987802 · An Indian Post Marketing Study of Mealtime Insulin, Fiasp®, to Evaluate Its Safety and Effectiveness in Patients With Diabetes Mellitus in Routine Clinical Practice

  Novo Nordisk A/S · completed · Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2 · study director
• Ph1
  NCT03965013 · A Study to Look at How Safe NNC0268-0965 is in Healthy People and People With Type 1 Diabetes

  Novo Nordisk A/S · completed · Diabetes Mellitus, Type 1, Healthy Volunteers · study director
• N/A
  NCT03960814 · A Study of All-Cause and Cardiovascular Mortality in Type 2 Diabetes Patients Using Basal Insulin Detemir and Glargine

  Novo Nordisk A/S · completed · Diabetes Mellitus, Type 2 · study director
• Ph2
  NCT03951805 · A Research Study to Compare Two Types of Insulin: Insulin 287 and Insulin Glargine in People With Type 2 Diabetes Who Have Not Used Insulin Before

  Novo Nordisk A/S · completed · Diabetes Mellitus, Type 2 · study director
• Ph1
  NCT03945656 · A Research Study of How Overdosing of a New Once Weekly Medicine NNC0148-0287 C (Insulin 287) Influences the Blood Sugar Level in People With Type 2 Diabetes

  Novo Nordisk A/S · completed · Diabetes Mellitus, Type 2 · study director
• N/A
  NCT03929679 · A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in The Netherlands, as Part of Local Clinical Practice (SURE NETHERLANDS)

  Novo Nordisk A/S · completed · Diabetes Mellitus, Type 2 · study director
• Ph2
  NCT03922750 · A Research Study in People With Type 2 Diabetes to Compare Two Types of Insulin: Insulin 287 and Insulin Glargine

  Novo Nordisk A/S · completed · Diabetes Mellitus, Type 2 · study director
• Ph3
  NCT03914326 · A Heart Disease Study of Semaglutide in Patients With Type 2 Diabetes

  Novo Nordisk A/S · completed · Diabetes Mellitus, Type 2 · study director
• Ph1
  NCT03905850 · A Study to Compare the Uptake Into the Blood of Two Strengths of Somapacitan After Injection Under the Skin in Healthy Subjects

  Novo Nordisk A/S · completed · Healthy Volunteers, Growth Hormone Deficiency · study director
• N/A
  NCT03895515 · Effect of Fiasp® in Type 1 Diabetes Treatment

  Novo Nordisk A/S · completed · Diabetes Mellitus, Type 1
• N/A
  NCT03888157 · A Research Study Looking at How Victoza® Works in People With Type 2 Diabetes in Iran, Followed in Local Clinical Routine

  Novo Nordisk A/S · completed · Diabetes Mellitus, Type 2 · study director
• Ph2
  NCT03878446 · A Research Study in Children Born Small and Who Stayed Small. Treatment is Somapacitan Once a Week Compared to Norditropin® Once a Day

  Novo Nordisk A/S · active not recruiting · Short Stature Children Born Small for Gestational Age (SGA)
• N/A
  NCT03876015 · A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in United Kingdom, as Part of Local Clinical Practice (SURE UK)

  Novo Nordisk A/S · completed · Diabetes Mellitus, Type 2 · study director
• N/A
  NCT03862690 · A Research Study, Looking at How NovoMix® Works in People With Type 2 Diabetes in Local Clinical Practice in Algeria

  Novo Nordisk A/S · withdrawn · Diabetes Mellitus, Type 2
• Ph2
  NCT03856047 · Research Study Investigating How Well NNC0174-0833 Works in People Suffering From Overweight or Obesity.

  Novo Nordisk A/S · completed · Overweight, Obesity · study director
• Ph1
  NCT03842202 · A Research Study to Look at How Semaglutide Affects Gastric Emptying in People With Obesity

  Novo Nordisk A/S · completed · Overweight, Obesity · study director
• N/A
  NCT03823339 · A Research Study, Looking at How Xultophy® Works in People With Type 2 Diabetes in Local Clinical Practice in United Arab Emirates

  Novo Nordisk A/S · completed · Diabetes Mellitus, Type 2 · study director
• Ph2
  NCT03816761 · Research Study to Look at Fast-acting Insulin Aspart With the Insulin Pump System 'iLet™' in Adults With Type 1 Diabetes

  Novo Nordisk A/S · completed · Diabetes Mellitus, Type 1 · study director
• Ph3
  NCT03811574 · STEP 6: Research Study Investigating How Well Semaglutide Works in People Living With Overweight or Obesity

  Novo Nordisk A/S · completed · Overweight, Obesity · study director
• N/A
  NCT03811288 · An International Survey of the Occurrence of Cardiovascular Disease Among Patients With Type 2 Diabetes

  Novo Nordisk A/S · completed · Diabetes Mellitus, Type 2 · study director
• Ph3
  NCT03811561 · A Research Study to Look at How Semaglutide Compared to Placebo Affects Diabetic Eye Disease in People With Type 2 Diabetes

  Novo Nordisk A/S · active not recruiting · Diabetes Mellitus, Type 2 · study director
• Ph4
  NCT03799198 · Real World Effectiveness of Combining an Employer-based Weight Management Program With Medication for Chronic Weight Management in Employees With Obesity

  Novo Nordisk A/S · completed · Obesity · study director
• N/A
  NCT03797885 · A Study of People With Type 2 Diabetes Who Have Diseases That Affect the Heart and Blood Vessels. The Study Will Also Look at the Treatment of a Group of These People in Hospitals in Portugal

  Novo Nordisk A/S · completed · Diabetes Mellitus, Type 2 · study director
• Ph1
  NCT03789578 · A Research Study to Look at How Insulin 287 and Semaglutide Work in the Body of People With Type 2 Diabetes When Taken Alone or Together

  Novo Nordisk A/S · completed · Diabetes Mellitus, Type 2 · study director
• Ph1
  NCT03787225 · A Research Study of How NNC0174-0833 Behaves in Japanese and Caucasian Volunteers Who Are Normal Weight, Overweight or With Obesity

  Novo Nordisk A/S · completed · Obesity, Overweight
• N/A
  NCT03786406 · An International Survey of the Occurrence of Diseases That Affects the Heart and Blood Vessels Among People With Type 2 Diabetes

  Novo Nordisk A/S · completed · Diabetes Mellitus, Type 2 · study director
• N/A
  NCT03785522 · A Research Study, Looking at How Tresiba® Works in People With Type 2 Diabetes in Local Clinical Practice in Saudi Arabia

  Novo Nordisk A/S · completed · Diabetes Mellitus, Type 2 · study director
• Ph1
  NCT03766854 · A Research Study of How Different Amounts of a New Medicine NNC0148-0287 C (Insulin 287) Works on the Blood Sugar of People Who Are Japanese With Type 1 Diabetes When Given Once a Week

  Novo Nordisk A/S · completed · Diabetes Mellitus, Type 1 · study director
• Ph2
  NCT03751657 · A Research Study to Compare Insulin 287 Once a Week to Insulin Glargine (100 Units/mL) Once a Day in People With Type 2 Diabetes.

  Novo Nordisk A/S · completed · Diabetes Mellitus, Type 2 · study director
• N/A
  NCT03745924 · A Study Following Males With Haemophilia B on Prophylaxis With Refixia/REBINYN

  Novo Nordisk A/S · enrolling by invitation · Haemophilia B · study director
• N/A
  NCT03745157 · RESILIENT: A Research Study, Looking at How Ryzodeg® Works in People With Type 2 Diabetes in Local Clinical Practice in Japan

  Novo Nordisk A/S · completed · Diabetes Mellitus, Type 2 · study director
• N/A
  NCT03741881 · A Study Following People With Haemophilia A and B, With or Without Inhibitors, When on Usual Treatment (Explorer™6)

  Novo Nordisk A/S · completed · Haemophilia A, Haemophilia A With Inhibitors, Haemophilia B · study director
• Ph1
  NCT03723785 · A Research Study of How a New Medicine NNC0148-0287 C (Insulin 287) Works in the Body of People With Kidney Problems

  Novo Nordisk A/S · completed · Diabetes Mellitus, Type 2 · study director
• Ph1
  NCT03723759 · A Research Study Looking at How Faster Aspart Injected in Double Concentration Works in the Body of People With Type 1 Diabetes Mellitus

  Novo Nordisk A/S · completed · Diabetes Mellitus, Type 1 · study director
• Ph1
  NCT03723772 · A Research Study of How Different Doses of a New Medicine NNC0148-0287 C (Insulin 287) Work on the Blood Sugar in People With Type 1 Diabetes When it is Taken Once a Week

  Novo Nordisk A/S · completed · Diabetes Mellitus, Type 1 · study director
• Ph1
  NCT03707990 · A Research Study of NNC0165-1875 Alone or Together With Semaglutide in People Who Are Overweight or Obese

  Novo Nordisk A/S · completed · Obesity and Overweight · study director
• Ph3
  NCT03693430 · Two-year Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or Obesity

  Novo Nordisk A/S · completed · Overweight, Obesity · study director
• Ph3
  NCT03689374 · A Research Study to Compare Semaglutide to Insulin Aspart, When Taken Together With Metformin and Insulin Glargine, in People With Type 2 Diabetes

  Novo Nordisk A/S · completed · Diabetes Mellitus, Type 2 · study director
• Ph4
  NCT03687827 · A Research Study to Compare the Effect of Insulin Degludec and Insulin Glargine on Blood Sugar Levels in People With Type 2 Diabetes - the SWITCH PRO Study

  Novo Nordisk A/S · completed · Diabetes Mellitus, Type 2 · study director
• N/A
  NCT03674866 · A Canadian Study of the Effectiveness of Tresiba® (Insulin Degludec) After Switching Basal Insulin in a Population With Type 1 or Type 2 Diabetes Mellitus

  Novo Nordisk A/S · completed · Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2 · study director
• N/A
  NCT03672617 · Validation of a Questionnaire That Identifies the Reasons for Non-adherence to Existing Growth Hormone Therapy

  Novo Nordisk A/S · completed · Growth Hormone Deficiency in Children · study director
• N/A
  NCT03660774 · A Study of the Impact of Hemophilia and Its Treatment on Brain Development, Thinking and Behaviour in Children With Hemophilia

  Novo Nordisk A/S · completed · Haemophilia A, Haemophilia B · study director
• Ph1
  NCT03661879 · Research Study of a New Medicine (NNC9204-1706) in People With Overweight or Obesity

  Novo Nordisk A/S · completed · Metabolism and Nutrition Disorder, Obesity · study director
• N/A
  NCT03648281 · A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Denmark and Sweden, as Part of Local Clinical Practice (SURE DENMARK/SWEDEN)

  Novo Nordisk A/S · completed · Diabetes Mellitus, Type 2 · study director
• Ph1
  NCT03638778 · Research Study Comparing Different Tablets With the Study Medicine Semaglutide in Healthy Men

  Novo Nordisk A/S · completed · Diabetes Mellitus, Type 2 · study director
• N/A
  NCT03631186 · A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Switzerland, as Part of Local Clinical Practice (SURE SWITZERLAND)

  Novo Nordisk A/S · completed · Diabetes Mellitus, Type 2 · study director
• Ph1
  NCT03617081 · First Research Study of the Possible New Medicine NNC0113-2023 in Healthy Men.

  Novo Nordisk A/S · completed · Diabetes Mellitus, Type 2 · study director
• Ph1
  NCT03611322 · A Trial to Compare Blood Concentration Levels of Semaglutide Following Subcutaneous Injections of Semaglutide 1 mg by 2 Different Devices (the DV3372 Device and by the PDS290 Semaglutide Pen-injector)

  Novo Nordisk A/S · completed · Diabetes Mellitus, Type 2 · study director
• Ph3
  NCT03611582 · Research Study to Look at How Well Semaglutide is at Lowering Weight When Taken Together With an Intensive Lifestyle Program

  Novo Nordisk A/S · completed · Overweight, Obesity · study director
• Ph1
  NCT03598621 · A Research Study to Look at Similarity Between Semaglutide Versions in Different Injection Tools

  Novo Nordisk A/S · completed · Diabetes Mellitus, Type 2 · study director
• Ph1
  NCT03600480 · A Research Study of How NNC0174-0833 Taken With Semaglutide Works in People Who Are Overweight or Obese

  Novo Nordisk A/S · completed · Obesity, Overweight
• Ph4
  NCT03596450 · Long Term Comparative Effectiveness of Once Weekly Semaglutide Versus Standard of Care in a Real World Adult US Population With Type 2 Diabetes - a Randomized Pragmatic Trial

  Novo Nordisk A/S · completed · Diabetes Mellitus, Type 2 · study director
• Ph3
  NCT03588741 · Evaluation of Safety Following Immune Tolerance Induction Treatment With Turoctocog Alfa in Patients With Haemophilia A Following Inhibitor Development in NN7170-4213 Trial

  Novo Nordisk A/S · terminated · Haemophilia A · study director
• N/A
  NCT03584191 · Awareness, Care & Treatment In Obesity Management - An International Observation

  Novo Nordisk A/S · completed · Obesity · study director
• Ph1
  NCT03574584 · A Research Study of NNC0165-1562 and Semaglutide in People Who Are Overweight or Obese

  Novo Nordisk A/S · completed · Metabolism and Nutrition Disorders, Overweight or Obesity · study director
• N/A
  NCT03560336 · A Regulatory Post-marketing Surveillance (rPMS) Study to Evaluate the Safety and Effectiveness of Saxenda®(Liraglutide 3.0 mg) in Obese Patients and Overweight Patients With Obesity-related Comorbidities in Routine Clinical Practice in Korea.

  Novo Nordisk A/S · completed · Obesity, Overweight · study director
• Ph3
  NCT03552757 · Research Study Investigating How Well Semaglutide Works in People With Type 2 Diabetes Suffering From Overweight or Obesity

  Novo Nordisk A/S · completed · Obesity, Overweight · study director
• Ph3
  NCT03548987 · Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or Obesity

  Novo Nordisk A/S · completed · Metabolism and Nutrition Disorder, Obesity · study director
• Ph3
  NCT03548935 · STEP 1: Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or Obesity

  Novo Nordisk A/S · completed · Metabolism and Nutrition Disorder, Overweight or Obesity · study director
• Ph1
  NCT03479892 · A Research Study Looking at a New Study Medicine (NNC0194-0499) for Weight Control in People With Overweight or Obesity

  Novo Nordisk A/S · completed · Metabolism and Nutrition Disorder, Obesity · study director
• Ph1
  NCT03466567 · A Trial Investigating the Effect of Probenecid and Ciclosporin on the Concentrations of SNAC in Healthy Subjects

  Novo Nordisk A/S · completed · Diabetes, Diabetes Mellitus, Type 2 · study director
• N/A
  NCT03457012 · A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Canada, as Part of Local Clinical Practice

  Novo Nordisk A/S · completed · Diabetes Mellitus, Type 2 · study director
• N/A
  NCT03450863 · Study on How Fiasp® Can Influence Blood Sugar Levels of type1 Diabetic Patients in Their Daily Lives, With the Help of the Freestyle Libre® Device

  Novo Nordisk A/S · completed · Diabetes, Diabetes Mellitus, Type 1 Diabetes · study director
• Ph1
  NCT03444467 · First Research Study to Compare a Possible New Medicine NNC9204-1513 to the Medicine Glucagon, in Healthy People.

  Novo Nordisk A/S · completed · Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2 · study director
• N/A
  NCT03435627 · Post Marketing Surveillance on Long-term Use With Norditropin® (Short Stature Due to Noonan Syndrome)

  Novo Nordisk A/S · completed · Genetic Disorder, Noonan Syndrome · study director
• N/A
  NCT03430154 · Awareness, Care, and Treatment In Obesity Management of Patients With Hemophilia (ACTION) to Inform Hemophilia Obesity Patient Empowerment (HOPE)

  Novo Nordisk A/S · completed · Haemophilia A, Haemophilia B, Obesity · study director
• N/A
  NCT03416855 · A Regulatory Post Marketing Surveillance (rPMS) Study of Ryzodeg® FlexTouch® (Insulin Degludec /Insulin Aspart) to Evaluate Safety and Effectiveness in Patients With Diabetes Mellitus in Routine Clinical Practice in Korea

  Novo Nordisk A/S · completed · Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2 · study director
• Ph1
  NCT03407599 · A Trial Comparing the Pharmacokinetic Properties of Fast-acting Insulin Aspart Between Children, Adolescents and Adults With Type 1 Diabetes

  Novo Nordisk A/S · completed · Diabetes, Diabetes Mellitus, Type 1 · study director
• N/A
  NCT03374774 · A Non-interventional Study of Ability and Willingness to Pay for BIAsp 30 in a Real World Population With Type 2 Diabetes Mellitus (T2DM)

  Novo Nordisk A/S · completed · Diabetes, Diabetes Mellitus, Type 2
• Ph1
  NCT03357380 · A Study on How Semaglutide Works on Early Stages of Scar Tissue in the Liver Assessed by Pictures of the Liver

  Novo Nordisk A/S · completed · Hepatobiliary Disorders, Non-alcoholic Fatty Liver Disease · study director
• Ph4
  NCT02582242 · Comparing Efficacy and Safety of Thrice Daily Versus Twice Daily NovoMix® 30 (Biphasic Insulin Aspart 30) in Subjects With Type 2 Diabetes Inadequately Controlled With Basal Insulin

  Novo Nordisk A/S · completed · Diabetes, Type 2 Diabetes Mellitus · study director
• Ph3
  NCT02505334 · A Trial Comparing the Efficacy and Safety of Liraglutide 1.8 mg/Day to Liraglutide 0.9 mg/Day in Japanese Subjects With Type 2 Diabetes Mellitus.

  Novo Nordisk A/S · completed · Diabetes, Diabetes Mellitus, Type 2
• Ph3
  NCT02229851 · Trial to Compare the Efficacy and Safety of NNC0195-0092 (Somapacitan) With Placebo and Norditropin® FlexPro® (Somatropin) in Adults With Growth Hormone Deficiency.

  Novo Nordisk A/S · completed · Growth Hormone Disorder, Adult Growth Hormone Deficiency · study director

Grants

NIH projects from RePORTER, fetched 2026-11-12 11:20 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.